April 10, 2025 USA
T1D Th1nk Tank: Ulf Hannelius joins us to discuss translating genetic insights into clinical progress
Diamyd Medical’s CEO Ulf Hannelius discusses genetic insights into clinical progress - the evolution of Diamyd Medical's antigen-specific immunotherapy.
The Sugar Science is an interactive digital platform founded to curate the scientific conversation among type 1 diabetes (T1D) researchers.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.